Author(s): Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB,
Abstract Share this page
Abstract BACKGROUND: Recent studies suggest that psoriasis, particularly if severe, may be a risk factor for major adverse cardiac events, such as myocardial infarction, stroke, and mortality from cardiovascular disease. We compared the risk of major adverse cardiac events between patients with psoriasis and the general population and estimated the attributable risk of severe psoriasis. METHODS: We performed a cohort study in the General Practice Research Database. Severe psoriasis was defined as receiving a psoriasis diagnosis and systemic therapy (N=3603). Up to 4 patients without psoriasis were selected from the same practices and start dates for each patient with psoriasis (N=14,330). RESULTS: Severe psoriasis was a risk factor for major adverse cardiac events (hazard ratio 1.53; 95\% confidence interval, 1.26-1.85) after adjusting for age, gender, diabetes, hypertension, tobacco use, and hyperlipidemia. After fully adjusted analysis, severe psoriasis conferred an additional 6.2\% absolute risk of 10-year major adverse cardiac events. CONCLUSION: Severe psoriasis confers an additional 6.2\% absolute risk of a 10-year rate of major adverse cardiac events compared with the general population. This potentially has important therapeutic implications for cardiovascular risk stratification and prevention in patients with severe psoriasis. Future prospective studies are needed to validate these findings. Copyright © 2011 Elsevier Inc. All rights reserved.
This article was published in Am J Med
and referenced in Dermatology Case Reports